drugset / Trial / NCT02592330

Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft

NCT02592330 ↗

NaSingle-groupOpen-labelTreatment

Summary

The main aim of the study is to determine the safety and feasibility of a cultivated autologous limbal epithelial cell (CALEC) transplantation in the treatment of limbal stem cell deficiency.

Timeline

Start
2016-08-01
Primary completion
2023-03-31
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cultivated Autologous Limbal Epithelial Cell Cell therapy — —